The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1.
-
- E L Berg
- Department of Pathology, Stanford University, California 94305.
-
- T Yoshino
- Department of Pathology, Stanford University, California 94305.
-
- L S Rott
- Department of Pathology, Stanford University, California 94305.
-
- M K Robinson
- Department of Pathology, Stanford University, California 94305.
-
- R A Warnock
- Department of Pathology, Stanford University, California 94305.
-
- T K Kishimoto
- Department of Pathology, Stanford University, California 94305.
-
- L J Picker
- Department of Pathology, Stanford University, California 94305.
-
- E C Butcher
- Department of Pathology, Stanford University, California 94305.
この論文をさがす
抄録
<jats:p>A skin-associated population of memory T lymphocytes, defined by expression of the cutaneous lymphocyte antigen (CLA), binds selectively and avidly to the vascular lectin endothelial cell-leukocyte adhesion molecule 1 (ELAM-1), an interaction that may be involved in targeting of CLA+ T cells to cutaneous sites of chronic inflammation. Here we present evidence that CLA itself is the (or a) lymphocyte homing receptor for ELAM-1. Antigen isolated with anti-CLA monoclonal antibody HECA-452 from human tonsillar lysates avidly binds ELAM-1 transfected mouse cells. Anti-CLA antibody blocks T lymphocyte binding to ELAM-1 transfectants. HECA-452 and ELAM-1 binding to lymphocytes or to isolated tonsillar HECA-452 antigen is abrogated by neuraminidase treatment implying a prominent role for sialic acid in CLA structure and function. The dominant form of CLA on T cells is immunologically distinct from the major neutrophil ELAM-1 ligand, the sialyl Lewis x (sLex) antigen (NeuAc alpha 2-3Gal beta 1-4[Fuc alpha 1-3]GlcNAc), which is absent, weakly expressed, or masked on T cells. However, neuraminidase treatment of CLA+ T cells, but not of CLA- T cells, reveals Lewis x (CD15) structures. In combination with the known requirement for terminal NeuAc alpha 2-3Gal and fucose residues attached to N-acetylglucosamine for ELAM-1 and HECA-452 binding, this finding suggests that CLA may comprise an additionally sialylated or otherwise modified form of sLex. The identification of a lymphocyte homing receptor for skin may permit novel approaches to the diagnosis and therapy of cutaneous and inflammatory disorders.</jats:p>
収録刊行物
-
- The Journal of experimental medicine
-
The Journal of experimental medicine 174 (6), 1461-1466, 1991-12-01
Rockefeller University Press
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1361699996249053824
-
- NII論文ID
- 30017429922
-
- NII書誌ID
- AA00697559
-
- ISSN
- 15409538
- 00221007
-
- データソース種別
-
- Crossref
- CiNii Articles